ArticleExperimental and therapeutic medicine2021

HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway.

Jing Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.